{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T22:22:17Z","timestamp":1792621337353,"version":"4.5.0"},"reference-count":81,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T00:00:00Z","timestamp":1747008000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institutes of Health National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI121135"],"award-info":[{"award-number":["R01AI121135"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institutes of Health National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U19AI149646-01"],"award-info":[{"award-number":["U19AI149646-01"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS076991-01"],"award-info":[{"award-number":["R01NS076991-01"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["UG3HL147367\\u201301"],"award-info":[{"award-number":["UG3HL147367\\u201301"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["R01HL152723\\u201302"],"award-info":[{"award-number":["R01HL152723\\u201302"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["R01HL097088"],"award-info":[{"award-number":["R01HL097088"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["P01HL131471\\u201305"],"award-info":[{"award-number":["P01HL131471\\u201305"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007920","name":"University of Massachusetts Medical School","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007920","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Nucleic Acids"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.omtn.2025.102563","type":"journal-article","created":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T19:38:54Z","timestamp":1747251534000},"page":"102563","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["AAVone: A cost-effective, single-plasmid solution for efficient AAV production with reduced DNA impurities"],"prefix":"10.1016","volume":"36","author":[{"given":"Rongze","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ngoc Tam","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taylor","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengtian","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tapan","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiantao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxu","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danmeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuiping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lemin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuling","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haniya","family":"Zaidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiarui","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"May","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dabbu","family":"Jaijyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhui","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangping","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daozhan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip W.L.","family":"Tai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-7764-3067","authenticated-orcid":false,"given":"Qizhao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2025.102563_bib1","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/d41573-021-00017-7","article-title":"The clinical landscape for AAV gene therapies","volume":"20","author":"Kuzmin","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.omtn.2025.102563_bib2","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/s41573-019-0012-9","article-title":"Adeno-associated virus vector as a platform for gene therapy delivery","volume":"18","author":"Wang","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.omtn.2025.102563_bib3","doi-asserted-by":"crossref","first-page":"3515","DOI":"10.1016\/j.ymthe.2022.09.015","article-title":"AAV vectors: The Rubik\u2019s cube of human gene therapy","volume":"30","author":"Pupo","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2025.102563_bib4","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1089\/10430349950016861","article-title":"High-Titer Recombinant Adeno-Associated Virus Production from Replicating Amplicons and Herpes Vectors Deleted for Glycoprotein H","volume":"10","author":"Zhang","year":"1999","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtn.2025.102563_bib5","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1089\/10430340260355347","article-title":"Insect cells as a factory to produce adeno-associated virus type 2 vectors","volume":"13","author":"Urabe","year":"2002","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtn.2025.102563_bib6","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.omtm.2017.11.002","article-title":"A Robust System for Production of Superabundant VP1 Recombinant AAV Vectors","volume":"7","author":"Wang","year":"2017","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtn.2025.102563_bib7","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1038\/s41467-022-28738-2","article-title":"Self-attenuating adenovirus enables production of recombinant adeno-associated virus for high manufacturing yield without contamination","volume":"13","author":"Su","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2025.102563_bib8","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.omtm.2018.01.002","article-title":"Pharmacology of Recombinant Adeno-associated Virus Production","volume":"8","author":"Penaud-Budloo","year":"2018","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtn.2025.102563_bib9","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1016\/j.xphs.2021.03.024","article-title":"Manufacturing Challenges and Rational Formulation Development for AAV Viral Vectors","volume":"110","author":"Srivastava","year":"2021","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.omtn.2025.102563_bib10","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.tibtech.2023.04.002","article-title":"Challenges in scaling up AAV-based gene therapy manufacturing","volume":"41","author":"Jiang","year":"2023","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.omtn.2025.102563_bib11","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1089\/hum.2022.050","article-title":"Human and Insect Cell-Produced Recombinant Adeno-Associated Viruses Show Differences in Genome Heterogeneity","volume":"33","author":"Tran","year":"2022","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtn.2025.102563_bib12","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1128\/JVI.72.3.2224-2232.1998","article-title":"Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus","volume":"72","author":"Xiao","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.omtn.2025.102563_bib13","doi-asserted-by":"crossref","first-page":"10220","DOI":"10.1073\/pnas.1001673107","article-title":"A viral assembly factor promotes AAV2 capsid formation in the nucleolus","volume":"107","author":"Sonntag","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2025.102563_bib14","article-title":"The X Gene of Adeno-Associated Virus 2 (AAV2) Is Involved in Viral DNA Replication","volume":"9","author":"Cao","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.omtn.2025.102563_bib15","doi-asserted-by":"crossref","first-page":"6239","DOI":"10.1038\/s41467-021-26485-4","article-title":"The membrane associated accessory protein is an adeno-associated viral egress factor","volume":"12","author":"Elmore","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2025.102563_bib16","doi-asserted-by":"crossref","first-page":"662","DOI":"10.3390\/v12060662","article-title":"The Interplay between Adeno-Associated Virus and Its Helper Viruses","volume":"12","author":"Meier","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.omtn.2025.102563_bib17","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1089\/hum.2023.146","article-title":"A Novel Role for the Adenovirus L4 Region 22K and 33K Proteins in Adeno-Associated Virus Production","volume":"35","author":"Adsero","year":"2024","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtn.2025.102563_bib18","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1002\/bit.28412","article-title":"Critical challenges and advances in recombinant adeno-associated virus (rAAV) biomanufacturing","volume":"120","author":"Fu","year":"2023","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.omtn.2025.102563_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2023.103610","article-title":"Treatment to cure: Advancing AAV gene therapy manufacture","volume":"28","author":"Young","year":"2023","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.omtn.2025.102563_bib20","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1002\/bit.28068","article-title":"Only a small fraction of cells produce assembled capsids during transfection-based manufacturing of adeno-associated virus vectors","volume":"119","author":"Dash","year":"2022","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.omtn.2025.102563_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.biotechadv.2022.108017","article-title":"The cell density effect in animal cell-based bioprocessing: Questions, insights and perspectives","volume":"60","author":"Lavado-Garc\u00eda","year":"2022","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.omtn.2025.102563_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/biot.202300051","article-title":"Production of adeno-associated viral vector serotype 6 by triple transfection of suspension HEK293 cells at higher cell densities","volume":"18","author":"Mo\u00e7o","year":"2023","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.omtn.2025.102563_bib23","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.omtm.2023.01.002","article-title":"Production of rAAV by plasmid transfection induces antiviral and inflammatory responses in suspension HEK293 cells","volume":"28","author":"Chung","year":"2023","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtn.2025.102563_bib24","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1016\/j.ymthe.2023.07.025","article-title":"Stowaways in the cargo: Contaminating nucleic acids in rAAV preparations for gene therapy","volume":"31","author":"Brimble","year":"2023","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2025.102563_bib25","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3390\/biomedicines2010080","article-title":"Product-Related Impurities in Clinical-Grade Recombinant AAV Vectors: Characterization and Risk Assessment","volume":"2","author":"Wright","year":"2014","journal-title":"Biomedicines"},{"key":"10.1016\/j.omtn.2025.102563_bib26","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1038\/mt.2011.182","article-title":"New Generation of Plasmid Backbones Devoid of Antibiotic Resistance Marker for Gene Therapy Trials","volume":"19","author":"Vandermeulen","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2025.102563_bib27","doi-asserted-by":"crossref","DOI":"10.1038\/mtna.2016.60","article-title":"DNA Minicircle Technology Improves Purity of Adeno-associated Viral Vector Preparations","volume":"5","author":"Schn\u00f6dt","year":"2016","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2025.102563_bib28","series-title":"Adeno-Associated Virus Vectors Methods in Molecular Biology","first-page":"85","article-title":"Single-Stranded DNA Virus Sequencing (SSV-Seq) for Characterization of Residual DNA and AAV Vector Genomes","author":"Lecomte","year":"2019"},{"key":"10.1016\/j.omtn.2025.102563_bib29","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.omtm.2018.02.002","article-title":"Adeno-associated Virus Genome Population Sequencing Achieves Full Vector Genome Resolution and Reveals Human-Vector Chimeras","volume":"9","author":"Tai","year":"2018","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtn.2025.102563_bib30","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.ymthe.2005.06.003","article-title":"Evidence for Encapsidation of Prokaryotic Sequences during Recombinant Adeno-Associated Virus Production and Their in Vivo Persistence after Vector Delivery","volume":"12","author":"Chadeuf","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2025.102563_bib31","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1146\/annurev-med-043021-033013","article-title":"Adeno-Associated Virus Gene Therapy for Hemophilia","volume":"74","author":"Samelson-Jones","year":"2023","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.omtn.2025.102563_bib32","doi-asserted-by":"crossref","DOI":"10.1172\/JCI173510","article-title":"Thrombotic microangiopathy following systemic AAV administration is dependent on anti-capsid antibodies","volume":"134","author":"Salabarria","year":"2024","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.omtn.2025.102563_bib33","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.omtm.2023.07.002","article-title":"Inducible HEK293 AAV packaging cell lines expressing Rep proteins","volume":"30","author":"Jal\u0161i\u0107","year":"2023","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtn.2025.102563_bib34","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/mt.2015.187","article-title":"Production of Recombinant Adeno-associated Virus Vectors Using Suspension HEK293 Cells and Continuous Harvest of Vector From the Culture Media for GMP FIX and FLT1 Clinical Vector","volume":"24","author":"Grieger","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2025.102563_bib35","doi-asserted-by":"crossref","first-page":"S145","DOI":"10.1016\/j.jcyt.2024.03.285","article-title":"UNIVERSAL AAV ENHANCER FOR IMPROVED VIRAL TITERS, QUALITY AND REDUCED PRODUCTION COSTS ACROSS SUSPENSION HEK PLATFORMS","volume":"26","author":"Reese","year":"2024","journal-title":"Cytotherapy"},{"key":"10.1016\/j.omtn.2025.102563_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e15071","article-title":"AAV genome modification for efficient AAV production","volume":"9","author":"Asaad","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.omtn.2025.102563_bib37","doi-asserted-by":"crossref","first-page":"e0077321","DOI":"10.1128\/JVI.00773-21","article-title":"Improved Genome Packaging Efficiency of Adeno-associated Virus Vectors Using Rep Hybrids","volume":"95","author":"Mietzsch","year":"2021","journal-title":"J. Virol."},{"key":"10.1016\/j.omtn.2025.102563_bib38","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/biot.201500176","article-title":"Rational plasmid design and bioprocess optimization to enhance recombinant adeno-associated virus (AAV) productivity in mammalian cells","volume":"11","author":"Emmerling","year":"2016","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.omtn.2025.102563_bib39","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1089\/hum.1998.9.18-2745","article-title":"Novel tools for production and purification of recombinant adenoassociated virus vectors","volume":"9","author":"Grimm","year":"1998","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtn.2025.102563_bib40","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1089\/biores.2020.0031","article-title":"Two-Plasmid Packaging System for Recombinant Adeno-Associated Virus","volume":"9","author":"Tang","year":"2020","journal-title":"Biores. Open Access"},{"key":"10.1016\/j.omtn.2025.102563_bib41","doi-asserted-by":"crossref","first-page":"3792","DOI":"10.1093\/nar\/27.19.3792","article-title":"Plasmid DNA size does not affect the physicochemical properties of lipoplexes but modulates gene transfer efficiency","volume":"27","author":"Kreiss","year":"1999","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2025.102563_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0167537","article-title":"Effects of Circular DNA Length on Transfection Efficiency by Electroporation into HeLa Cells","volume":"11","author":"Hornstein","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.omtn.2025.102563_bib43","doi-asserted-by":"crossref","DOI":"10.1038\/mtna.2016.4","article-title":"Overcoming the Specific Toxicity of Large Plasmids Electrotransfer in Primary Cells In Vitro","volume":"5","author":"Lesueur","year":"2016","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2025.102563_bib44","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.omtm.2023.05.004","article-title":"A novel dual-plasmid platform provides scalable transfection yielding improved productivity and packaging across multiple AAV serotypes and genomes","volume":"29","author":"Van Lieshout","year":"2023","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtn.2025.102563_bib45","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.omtm.2021.03.016","article-title":"Development of a scalable and robust AEX method for enriched rAAV preparations in genome-containing VCs of serotypes 5, 6, 8, and 9","volume":"21","author":"Joshi","year":"2021","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtn.2025.102563_bib46","doi-asserted-by":"crossref","first-page":"5785","DOI":"10.1073\/pnas.1821000116","article-title":"AAV cis -regulatory sequences are correlated with ocular toxicity","volume":"116","author":"Xiong","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2025.102563_bib47","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1089\/hum.2021.132","article-title":"Low-Dose Recombinant Adeno-Associated Virus-Mediated Inhibition of Vascular Endothelial Growth Factor Can Treat Neovascular Pathologies Without Inducing Retinal Vasculitis","volume":"32","author":"Cheng","year":"2021","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtn.2025.102563_bib48","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abd3438","article-title":"Engineering adeno-associated viral vectors to evade innate immune and inflammatory responses","volume":"13","author":"Chan","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omtn.2025.102563_bib49","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/s41434-024-00477-7","article-title":"The AAV2.7m8 capsid packages a higher degree of heterogeneous vector genomes than AAV2","volume":"31","author":"Cui","year":"2024","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtn.2025.102563_bib50","first-page":"1187","article-title":"Direct ITR-to-ITR nanopore sequencing of AAV vector genomes","volume":"33","author":"Namkung","year":"2022","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtn.2025.102563_bib51","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.omtn.2022.08.027","article-title":"Subgenomic particles in rAAV vectors result from DNA lesion\/break and non-homologous end joining of vector genomes","volume":"29","author":"Zhang","year":"2022","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2025.102563_bib52","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.ymthe.2017.03.028","article-title":"Short DNA Hairpins Compromise Recombinant Adeno-Associated Virus Genome Homogeneity","volume":"25","author":"Xie","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2025.102563_bib53","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2023.1106085","article-title":"AAV- based vector improvements unrelated to capsid protein modification","volume":"10","author":"Shitik","year":"2023","journal-title":"Front. Med."},{"key":"10.1016\/j.omtn.2025.102563_bib54","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1089\/hgtb.2019.276","article-title":"A User\u2019s Guide to the Inverted Terminal Repeats of Adeno-Associated Virus","volume":"30","author":"Wilmott","year":"2019","journal-title":"Hum. Gene Ther. Methods"},{"key":"10.1016\/j.omtn.2025.102563_bib55","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.omtm.2020.07.007","article-title":"AAV-Genome Population Sequencing of Vectors Packaging CRISPR Components Reveals Design-Influenced Heterogeneity","volume":"18","author":"Tran","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtn.2025.102563_bib56","first-page":"33","article-title":"Quantitative risk assessment of limits for residual host-cell DNA: ensuring patient safety for in vitro gene therapies produced using human-derived cell lines","volume":"21","author":"Muralidharan","year":"2023","journal-title":"Bioprocess Int."},{"key":"10.1016\/j.omtn.2025.102563_bib57","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.3390\/v15061228","article-title":"Querying Recombination Junctions of Replication-Competent Adeno-Associated Viruses in Gene Therapy Vector Preparations with Single Molecule, Real-Time Sequencing","volume":"15","author":"Yip","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.omtn.2025.102563_bib58","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3390\/ph15010023","article-title":"PCR-Based Analytical Methods for Quantification and Quality Control of Recombinant Adeno-Associated Viral Vector Preparations","volume":"15","author":"Shmidt","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.omtn.2025.102563_bib59","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jviromet.2013.06.008","article-title":"AAV2 production with optimized N\/P ratio and PEI-mediated transfection results in low toxicity and high titer for in vitro and in vivo applications","volume":"193","author":"Huang","year":"2013","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.omtn.2025.102563_bib60","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jviromet.2013.10.038","article-title":"Production of adeno-associated virus (AAV) serotypes by transient transfection of HEK293 cell suspension cultures for gene delivery","volume":"196","author":"Chahal","year":"2014","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.omtn.2025.102563_bib61","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.omtm.2020.06.004","article-title":"Creation of a High-Yield AAV Vector Production Platform in Suspension Cells Using a Design-of-Experiment Approach","volume":"18","author":"Zhao","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtn.2025.102563_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2024.101230","article-title":"Producing high-quantity and high-quality recombinant adeno-associated virus by low-cis triple transfection","volume":"32","author":"Liu","year":"2024","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtn.2025.102563_bib63","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0092-8674(83)90342-2","article-title":"Rescue of adeno-associated virus from recombinant plasmids: Gene correction within the terminal repeats of AAV","volume":"33","author":"Samulski","year":"1983","journal-title":"Cell"},{"key":"10.1016\/j.omtn.2025.102563_bib64","doi-asserted-by":"crossref","first-page":"11480","DOI":"10.1128\/JVI.77.21.11480-11490.2003","article-title":"Rescue of the Adeno-Associated Virus Genome from a Plasmid Vector: Evidence for Rescue by Replication","volume":"77","author":"Ward","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.omtn.2025.102563_bib65","doi-asserted-by":"crossref","first-page":"3494","DOI":"10.1128\/JVI.74.8.3494-3504.2000","article-title":"Productive Replication of Adeno-Associated Virus Can Occur in Human Papillomavirus Type 16 (HPV-16) Episome-Containing Keratinocytes and Is Augmented by the HPV-16 E2 Protein","volume":"74","author":"Ogston","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.omtn.2025.102563_bib66","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/bit.20776","article-title":"Scalable production of adeno-associated virus type 2 vectors via suspension transfection","volume":"94","author":"Park","year":"2006","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.omtn.2025.102563_bib67","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.omtm.2021.04.006","article-title":"Mechanistic model for production of recombinant adeno-associated virus via triple transfection of HEK293 cells","volume":"21","author":"Nguyen","year":"2021","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtn.2025.102563_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2024.101320","article-title":"Production of recombinant adeno-associated virus 5 using a novel self-attenuating adenovirus production platform","volume":"32","author":"Roach","year":"2024","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtn.2025.102563_bib69","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1038\/mt.2008.35","article-title":"Intron Splicing\u2013mediated Expression of AAV Rep and Cap Genes and Production of AAV Vectors in Insect Cells","volume":"16","author":"Chen","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2025.102563_bib70","doi-asserted-by":"crossref","first-page":"384","DOI":"10.3390\/microorganisms12020384","article-title":"Development of Stable Packaging and Producer Cell Lines for the Production of AAV Vectors","volume":"12","author":"Merten","year":"2024","journal-title":"Microorganisms"},{"key":"10.1016\/j.omtn.2025.102563_bib71","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.omtm.2016.12.004","article-title":"Syngeneic AAV Pseudo-particles Potentiate Gene Transduction of AAV Vectors","volume":"4","author":"Wang","year":"2017","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtn.2025.102563_bib72","article-title":"365. Characterization of Residual Plasmid DNA Impurities in Recombinant AAV; Correlation with Size of Transgene Expression Cassette","volume":"20","author":"Zelenaia","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2025.102563_bib73","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/mt.2008.227","article-title":"Undetectable Transcription of cap in a Clinical AAV Vector: Implications for Preformed Capsid in Immune Responses","volume":"17","author":"Hauck","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2025.102563_bib74","doi-asserted-by":"crossref","first-page":"6816","DOI":"10.1128\/jvi.71.9.6816-6822.1997","article-title":"Identification and elimination of replication-competent adeno-associated virus (AAV) that can arise by nonhomologous recombination during AAV vector production","volume":"71","author":"Allen","year":"1997","journal-title":"J. Virol."},{"key":"10.1016\/j.omtn.2025.102563_bib75","doi-asserted-by":"crossref","first-page":"6609","DOI":"10.1093\/nar\/gkt404","article-title":"A concept of eliminating nonhomologous recombination for scalable and safe AAV vector generation for human gene therapy","volume":"41","author":"Dong","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2025.102563_bib76","doi-asserted-by":"crossref","first-page":"11456","DOI":"10.1128\/JVI.74.24.11456-11463.2000","article-title":"High-Titer, Wild-Type Free Recombinant Adeno-Associated Virus Vector Production Using Intron-Containing Helper Plasmids","volume":"74","author":"Cao","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.omtn.2025.102563_bib77","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0140829","article-title":"Genomics Virtual Laboratory: A Practical Bioinformatics Workbench for the Cloud","volume":"10","author":"Afgan","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.omtn.2025.102563_bib78","doi-asserted-by":"crossref","DOI":"10.1002\/0471142727.mb1910s89","article-title":"Galaxy: A Web-Based Genome Analysis Tool for Experimentalists","volume":"89","author":"Blankenberg","year":"2010","journal-title":"Curr. Protoc. Mol. Biol."},{"key":"10.1016\/j.omtn.2025.102563_bib79","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1101\/gr.4086505","article-title":"Galaxy: A platform for interactive large-scale genome analysis","volume":"15","author":"Giardine","year":"2005","journal-title":"Genome Res."},{"key":"10.1016\/j.omtn.2025.102563_bib80","doi-asserted-by":"crossref","first-page":"R86","DOI":"10.1186\/gb-2010-11-8-r86","article-title":"Galaxy: a comprehensive approach for supporting accessible, reproducible, and transparent computational research in the life sciences","volume":"11","author":"Goecks","year":"2010","journal-title":"Genome Biol."},{"key":"10.1016\/j.omtn.2025.102563_bib81","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/nbt.1754","article-title":"Integrative genomics viewer","volume":"29","author":"Robinson","year":"2011","journal-title":"Nat. Biotechnol."}],"container-title":["Molecular Therapy Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253125001179?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253125001179?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T04:42:33Z","timestamp":1763354553000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253125001179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":81,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S2162253125001179"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2025.102563","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2025.01.07.631712","asserted-by":"object"}]},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AAVone: A cost-effective, single-plasmid solution for efficient AAV production with reduced DNA impurities","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2025.102563","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"102563"}}